Fundz

Who to call at Diag-Nose.io, and when

Fundz watches for the moments Diag-Nose.io starts buying, and tells you who to reach.

  • An alert the day Diag-Nose.io raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Diag-Nose.io, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Diag-Nose.io Opens Houston Office following $2M Seed Round

Jan 30, 2025

Contract Type

partnership

BethlehemBiotechnologyHealth CareArtificial IntelligenceTherapeuticsHealth Diagnostics

Description

Diag-Nose.io has opened a new office in Houston, Texas, following the successful completion of its oversubscribed $2 million seed round. The fundraise marks a significant step forward in the company's mission to transform respiratory care using advanced proteomics and artificial intelligence.

Company Information

Company

Diag-Nose.io

Location

Bethlehem, Pennsylvania, United States

About

Diag-Nose.io is a biotechnology company founded in 2020, focusing on precision diagnostic and drug discovery solutions for chronic respiratory diseases. Their technology integrates advanced proteomics, computational biology, and AI to enhance treatment prescription and accelerate new therapy development. The flagship platform, RhinoMAP™, aims to predict respiratory disease activity and monitor treatment efficacy. Diag-Nose.io's innovative approach seeks to transform respiratory healthcare through data-driven personalized care.

Related People

Brian
Likely contact at this company
••••••••@••••••••

See Brian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Diag-Nose.io's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Diag-Nose.io signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.